Today: 29 January 2026
Subscribe
Browse Category

NASDAQ:FEED News 29 January 2026

ENvue Medical stock pulls back in premarket after 119% surge on U-Deliver distribution deal

ENvue Medical stock pulls back in premarket after 119% surge on U-Deliver distribution deal

New York, January 29, 2026, 05:34 EST — Premarket ENvue Medical shares dropped roughly 10% in early trading Thursday, following a surge of more than 100% the day before. At 5:31 a.m. ET, the stock traded at $2.06, down from Wednesday’s close of $2.30, which had marked a 119% jump. (Investing) The move is significant since ENvue is a micro-cap…
29 January 2026
····

Stock Market Today

  • Agomab Therapeutics targets $182 million Nasdaq IPO to advance fibrosis pipeline
    January 29, 2026, 9:35 AM EST. Belgian fibrosis biotech Agomab Therapeutics plans to raise approximately $182 million in net proceeds from its proposed Nasdaq initial public offering (IPO). The company intends to sell 12.5 million shares to fund development of treatments for fibrosis, a condition marked by excessive tissue scarring. Agomab aims to use the capital to advance its drug pipeline targeting fibrotic diseases. The IPO reflects growing interest in biotech firms focused on chronic, hard-to-treat illnesses. Agomab is positioning itself to capitalize on this demand with innovative therapeutic options.
Go toTop